
|Videos|September 15, 2015
Will There Be Hesitancy to Prescribe Biosimilars?
Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.
Advertisement
Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.
This video was recorded at the 2015 NACDS Total Store Expo.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients
2
Pharmacists Are Critical to SGLT2, GLP-1 Use in CKD
3
Why COVID-19 Prevention Still Matters During 2026's Summer Surge
4
FDA Expands Lutetium Lu 177 Vipivotide Tetraxetan to mHSPC, Nearly Doubling Eligible Population
5






































































































